Advertisement

In Vitro\Ex Vivo Generation of Cytotoxic T Lymphocytes

  • Margherita Gigante
  • Elena RanieriEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1186)

Abstract

The in vitro generation of human cytotoxic T lymphocytes (CTL) is a reliably approach useful not only to assess intrinsic CD8+ T cell responses in individuals but also to screen immunogenic antigens that could be considered as candidates for adoptive immunotherapeutic approaches. In vitro methods to expand CTL require culturing naïve T cells with antigen-presenting cells (APC) as stimulator cells that express specific antigens. Here, we describe the protocol for generating CTL against target antigens presented by monocyte-derived dendritic cells (DCs).

Key words

CD8+ T cell Cytotoxicity Dendritic cells Peptides Cancer 

Notes

Acknowledgments

This work was supported by Progetto Strategico Regione Puglia grant (E.R., 2008), Ministero dell’Istruzione, dell’Università e della Ricerca (MiUR) FIRB, CAROMICS grant (E.R., 2011), and a Postdoctoral Fellowship by MiUR, PROGRAMMA OPERATIVO NAZIONALE (PON) RICERCA E COMPETITIVITÀ 2007–2013 PONa3_00395 “BIOSCIENCES AND HEALTH” (B&H) (M.G., 2013). The authors declare no conflicts of interest.

References

  1. 1.
    Williams MA, Bevan MJ (2007) Effector and memory CTL differentiation. Annu Rev Immunol 25:171–192PubMedCrossRefGoogle Scholar
  2. 2.
    Biddison WE, Lichtenfels R, Adibzadeh M, Martin R (2001) Measurement of polyclonal and antigen-specific cytotoxic T cell function. Curr Protoc Immunol. Chapter 7: Unit 7.17. doi: 10.1002/0471142735.im0717s17Google Scholar
  3. 3.
    Gigante M, Mandic M, Wesa AK et al (2008) Interferon-alpha (IFN-alpha)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patients. J Immunother 31:254–262. doi: 10.1097/CJI.0b013e318167b023 PubMedCrossRefGoogle Scholar
  4. 4.
    Ho WY, Nguyen HN, Wolfl M, Kuball J, Greenberg PD (2006) In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naïve repertoire. J Immunol Methods 310:40–52PubMedCrossRefGoogle Scholar
  5. 5.
    Santin AD, Hermonat PL, Ravaggi A et al (2000) In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer. Am J Obstet Gynecol 183:601–609PubMedCrossRefGoogle Scholar
  6. 6.
    Buchler T, Hajek R, Bourkova L et al (2003) Generation of antigen-loaded dendritic cells in a serum-free medium using different cytokine combinations. Vaccine 21:877–882PubMedCrossRefGoogle Scholar
  7. 7.
    de Vries IJ, Lesterhuis WJ, Scharenborg NM et al (2003) Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients. Clin Cancer Res 9:5091–5100PubMedGoogle Scholar
  8. 8.
    Turtle CJ, Hart DN (2004) Dendritic cells in tumor immunology and immunotherapy. Curr Drug Targets 5:17–39PubMedCrossRefGoogle Scholar
  9. 9.
    Gitlitz BJ, Belldegrun AS, Zisman A et al (2003) A pilot trial of tumor lysate-loaded dendritic cells for the treatment of metastatic renal cell carcinoma. J Immunother 26:412–419PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Nephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, PoliclinicoUniversity of Bari “A. Moro”BariItaly
  2. 2.Department of Surgical and Medical, Sciences, School of Medicine, Ospedali RiunitiUniversity of FoggiaFoggiaItaly

Personalised recommendations